Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Cognition in T2DM
NCT01206322Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- May 2010
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of regular human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoints: Brief Visuospatial Spatial Memory Test - Total Recall at 2 hours and Right Insular Cortex Perfusion at 2 hours. Started May 2010; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01206322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206322.